Additionally, although in vitro experiments have confirmed the regulatory role of SF3B6 in the proliferation, migration, and apoptosis of HCC cells, the lack of animal models to validate its in vivo oncogenic function and its impact on the tumor microenvironment limits a comprehensive evaluation of its clinical translational potential in HCC. Here, SF3B6 is linked to hepatocellular carcinoma.